- Cinzia Colombo, researcher1,
- Rita Banzi, researcher2
- 1Laboratory of Medical Analysis on Shopper Involvement, Division of Medical Epidemiology, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy
- 2Centre for Well being Regulatory Insurance policies, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan
Angelis and colleagues debunk the argument that prime costs are wanted to maintain drug growth.1 Their evaluation refers to a big physique of proof exhibiting that the majority drug industries make investments extra in promoting, administrative actions—together with advertising and marketing—and share buybacks than analysis and growth. Moreover, a number of research discovered that new medication have little or no therapeutic added worth.
Drug costs instantly have an effect on folks with a illness, when it comes to …